769 related articles for article (PubMed ID: 22971657)
1. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
Zając-Spychała O; Wachowiak J
Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
[TBL] [Abstract][Full Text] [Related]
5. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
[TBL] [Abstract][Full Text] [Related]
6. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
[TBL] [Abstract][Full Text] [Related]
8. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
[TBL] [Abstract][Full Text] [Related]
9. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice.
Waber DP; Tarbell NJ; Fairclough D; Atmore K; Castro R; Isquith P; Lussier F; Romero I; Carpenter PJ; Schiller M
J Clin Oncol; 1995 Oct; 13(10):2490-6. PubMed ID: 7595698
[TBL] [Abstract][Full Text] [Related]
10. Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.
Zając-Spychała O; Pawlak MA; Karmelita-Katulska K; Pilarczyk J; Derwich K; Wachowiak J
Neuroradiology; 2017 Feb; 59(2):147-156. PubMed ID: 28074235
[TBL] [Abstract][Full Text] [Related]
11. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate.
Zając-Spychała O; Pawlak M; Karmelita-Katulska K; Pilarczyk J; Jończyk-Potoczna K; Przepióra A; Derwich K; Wachowiak J
Leuk Lymphoma; 2018 Oct; 59(10):2342-2351. PubMed ID: 29424258
[TBL] [Abstract][Full Text] [Related]
12. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
[TBL] [Abstract][Full Text] [Related]
14. Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia.
Lin WY; Liu HC; Yeh TC; Wang LY; Liang DC
Pediatr Blood Cancer; 2008 Mar; 50(3):523-7. PubMed ID: 17455314
[TBL] [Abstract][Full Text] [Related]
15. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
Kähkönen M; Metsähonkala L; Minn H; Utriainen T; Korhonen T; Norvasuo-Heilä MK; Harila-Saari A; Aärimaa T; Suhonen-Polvi H; Ruotsalainen U; Solin O; Salmi TT
Cancer; 2000 Feb; 88(3):693-700. PubMed ID: 10649265
[TBL] [Abstract][Full Text] [Related]
16. Analysis of growth failure in children treated for acute lymphoblastic leukemia.
Sato J; Ninomiya T; Tsuda Y; Komazawa M; Nagata K; Iwai A; Nishikawa K; Maeda H; Ohmiya A; Ohta M
Int J Hematol; 1992 Dec; 56(3):205-12. PubMed ID: 1477332
[TBL] [Abstract][Full Text] [Related]
17. Isolated central nervous system relapse in acute lymphocytic leukemia (ALL) in children. Experiences of the Swiss Pediatric Oncology Group (SPOG/SAKK) 1976-1986.
Stucki F; Arnet B; Baumgartner C; Beck D; Berchtold W; Bertrand AM; Bleher EA; Caflisch U; Delaleu B; Feldges A
Helv Paediatr Acta; 1988 Nov; 43(3):187-93. PubMed ID: 3065299
[TBL] [Abstract][Full Text] [Related]
18. Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report.
Stark B; Sharon R; Rechavi G; Attias D; Ballin A; Cividalli G; Burstein Y; Sthoeger D; Abramov A; Zaizov R
Cancer; 2000 Jan; 88(1):205-16. PubMed ID: 10618625
[TBL] [Abstract][Full Text] [Related]
19. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation.
Nathan PC; Maze R; Spiegler B; Greenberg ML; Weitzman S; Hitzler JK
Pediatr Blood Cancer; 2004 Jan; 42(1):24-9. PubMed ID: 14752790
[TBL] [Abstract][Full Text] [Related]
20. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
